Best Fertility Tests Before IVF That Matter

A fertility evaluation should do more than produce a stack of lab results. The best fertility tests before IVF help answer practical questions: Is IVF the right next step? Is there a factor that should change the treatment plan? And what can realistically be expected from a cycle?

For many patients, testing begins after months or years of uncertainty. A clear, physician-led review can replace scattered information with a strategy that considers age, medical history, prior pregnancies, prior treatment, and the specific reasons IVF is being considered. Not every available test is necessary for every person. The value is in choosing the tests that may meaningfully guide care.

Best fertility tests before IVF: Start with a complete assessment

A thoughtful IVF workup usually starts with a detailed consultation rather than a single test. Your physician should review menstrual patterns, prior pregnancies and losses, surgeries, pelvic pain, medications, family history, and any previous fertility treatment. If you have had unsuccessful IVF, the details of stimulation, egg maturity, fertilization, embryo development, and transfer history matter greatly.

This context determines which tests are useful and how to interpret them. For example, a low AMH result may call for a careful discussion of expected egg yield, but it does not independently measure egg quality or determine whether pregnancy is possible. Likewise, a normal ultrasound does not rule out every issue that could affect implantation.

Ovarian reserve testing

Ovarian reserve tests estimate the likely response to ovarian stimulation. They are especially useful when planning medication doses and setting expectations about the number of eggs that may be retrieved.

The most common measures are anti-Müllerian hormone, or AMH, antral follicle count on transvaginal ultrasound, and early-cycle follicle-stimulating hormone and estradiol levels. AMH is measured through bloodwork and generally reflects the pool of developing follicles. Antral follicle count is the number of small follicles visible in the ovaries at the beginning of a cycle.

These results are best considered together, not treated as a pass-or-fail score. Age remains a major predictor of egg chromosome health, while AMH and follicle count offer more information about quantity and expected response. Patients with low AMH or diminished ovarian reserve deserve individualized planning, not a dismissive conclusion based on one number.

Semen analysis and male-factor evaluation

A semen analysis remains one of the most useful tests before IVF, even when there has been a previous pregnancy or no obvious concern. It assesses semen volume, sperm concentration, movement, and shape. Results can help determine whether conventional IVF may be appropriate or whether intracytoplasmic sperm injection, known as ICSI, is more suitable.

An abnormal result does not always mean IVF is the only path, but it should be interpreted carefully. Fever, recent illness, medications, collection conditions, and timing can affect a sample. Repeating a significantly abnormal analysis may be reasonable before making major decisions.

In selected situations, further male-factor evaluation may be helpful. This can include a reproductive urology consultation, hormone testing, or sperm DNA fragmentation testing. Sperm DNA fragmentation is not a routine test for every patient. It may be considered when there is recurrent pregnancy loss, repeated poor embryo development, unexplained failed IVF, or certain semen abnormalities, but its role depends on the full clinical picture.

Uterine cavity and fallopian tube assessment

IVF bypasses the fallopian tubes for fertilization, but the uterine cavity still needs to provide an appropriate environment for embryo transfer. A transvaginal ultrasound can identify fibroids, ovarian cysts, adenomyosis features, and some uterine abnormalities. However, it may not show small polyps, scar tissue, or subtle changes inside the cavity.

A saline infusion sonogram, often called a saline sonogram, uses sterile fluid and ultrasound to outline the inside of the uterus. It can be a valuable, minimally invasive way to identify polyps, submucosal fibroids, adhesions, or a uterine septum. Hysteroscopy may be recommended when imaging suggests an issue that needs direct evaluation or treatment.

Tubal testing is not required in every IVF case, but it can be important when there is a history of pelvic infection, ectopic pregnancy, endometriosis, prior tubal surgery, or suspected hydrosalpinx. A hydrosalpinx is a fluid-filled, damaged fallopian tube. Its presence can reduce implantation rates and should be addressed before embryo transfer. Depending on the history, an HSG, ultrasound, or other imaging may be used to assess the tubes.

Hormone tests that can change an IVF plan

Hormone testing should be purposeful. In addition to ovarian reserve markers, thyroid-stimulating hormone is commonly checked because untreated thyroid dysfunction can affect reproductive and pregnancy health. Prolactin may be tested when cycles are irregular, ovulation is unclear, or there are symptoms suggesting elevated levels.

For patients with irregular periods, acne, excess facial hair, unexplained weight changes, or signs of ovulatory dysfunction, additional testing may evaluate for polycystic ovary syndrome, adrenal conditions, or other endocrine causes. Testing may include testosterone, DHEAS, 17-hydroxyprogesterone, glucose-related markers, or other labs based on symptoms.

The goal is not to test every hormone that can be measured. It is to identify conditions that could change stimulation safety, medication selection, transfer timing, or care during pregnancy.

Genetic testing: Useful when it answers a specific question

Carrier screening can identify whether intended genetic parents carry certain inherited conditions. It is commonly offered before IVF because, if both genetic parents carry a condition, the result may influence reproductive planning and whether preimplantation genetic testing for monogenic conditions is considered.

Karyotype testing looks for chromosome rearrangements in a parent. It is not necessary for all IVF patients, but it may be appropriate after recurrent pregnancy loss, certain family histories, or repeated embryos with chromosome abnormalities.

Preimplantation genetic testing for aneuploidy, or PGT-A, is different. It is performed on embryos created through IVF, not as a pre-cycle blood test. PGT-A may help identify embryos with the expected number of chromosomes, which can assist embryo selection in some situations. It does not create healthier embryos, improve egg quality, or guarantee a live birth. Whether it is worthwhile depends on age, embryo numbers, reproductive history, and personal priorities.

Infectious disease and pre-treatment health screening

Before IVF, clinics typically complete infectious disease testing for both partners or genetic contributors as required for safe laboratory handling and treatment planning. Depending on your health history, a physician may also review immunity status, blood type, blood count, metabolic health, and medications.

General health is part of fertility care, not an afterthought. Blood pressure, diabetes management, smoking, significant weight changes, sleep, and mental health can all affect how treatment is experienced and, in some cases, how pregnancy is managed. The right approach is supportive and practical, not judgmental. Few patients need to delay care for perfection; some need specific health issues stabilized so treatment can proceed more safely.

When more testing is not better testing

It is understandable to want every possible answer before beginning IVF. Yet broad testing without a clear reason can add cost, delay, and anxiety without improving decisions. Tests such as immune panels, endometrial receptivity assays, thrombophilia panels, and microbiome tests are sometimes discussed online or offered after failed treatment. Their usefulness is highly situation-dependent, and evidence for routine use is limited.

After one unsuccessful embryo transfer, for example, the most helpful next step is often a careful review of embryo quality, uterine findings, transfer details, and the original diagnosis rather than an automatic expansion into dozens of additional tests. Recurrent loss, repeated implantation failure, or unusual laboratory outcomes may justify a more specialized investigation.

A good fertility specialist explains not only what they recommend, but why. They should also be willing to explain when a test is unlikely to change the plan.

Turning results into a personal IVF strategy

The most valuable part of pre-IVF testing is the conversation that follows. Results should shape decisions about stimulation protocol, ICSI, the timing of treatment, uterine preparation, embryo testing, and whether a specialist consultation is needed before moving forward.

For international patients, this planning can often begin remotely. Records, ultrasound reports, laboratory results, and prior IVF cycle details can be reviewed before travel so there is less uncertainty once treatment begins. At Dr. Alex Aldape's practice, the emphasis is on direct physician involvement and a plan built around the information that actually matters for your care.

You do not need every answer before you start IVF. You need the right questions, a clear interpretation of the results, and a physician who can help you make decisions with both clinical rigor and realistic hope.